Human NSCLC samples, patient-derived xenografts, mouse models, and The Cancer Genome Atlas (TCGA) have all consistently showed high expression levels of GLUT1 in squamous cell carcinoma (Goodwin et al., 2017; Smolle et al., 2020). Here, SLC2A1 is linked to non-small cell lung carcinoma.